Stay updated on OPUS Clinical Trial: Natalizumab in Focal Epilepsy

Sign up to get notified when there's something new on the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page.
Latest website image capture
Clouds background image

Latest updates to the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision: v3.5.4 appears on the page, replacing the previous v3.5.3. This reflects an internal update to the page version without altering the study details or visible content.
    Difference
    0.0%
    Check dated 2026-05-15T23:51:55.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page’s displayed software/interface revision number has been updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T16:48:54.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The site revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T13:53:01.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page now shows an updated Revision tag: v3.5.0, replacing the previous v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T23:46:23.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-12T20:43:40.000Z thumbnail image
  9. Check
    104 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2 instead of v3.4.1; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T01:58:35.000Z thumbnail image

Stay in the know with updates to OPUS Clinical Trial: Natalizumab in Focal Epilepsy

Enter your email address, and we'll notify you when there's something new on the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page.